Independent pharmacies claim financial strain from opaque middlemen in drug pricing and distribution.

Independent pharmacies claim they are being financially strained by opaque middlemen associated with large health organizations. These intermediaries, often involved in drug pricing and distribution, are seen as profiting at the expense of both pharmacies and patients, raising concerns about transparency and fairness in the healthcare system. This situation highlights the challenges faced by small pharmacies in a competitive market dominated by larger entities.

September 01, 2024
6 Articles